References
- Brandon R. Legislative Hearings to Amend the Controlled Substance Act to Move Amphetamines and Certain Other Stimulant Substances from Schedule HI of Such A ct to Schedule II. Committee of the Judiciary, 92nd Congress. U.S. Government Printing Office, Washington, DC 1972
- Brooks G. F., O'Donoghue J. M., Rissing J. P., Soapes K., Smith J. W. Eikenella Corrodens, a recently recognized pathogen: Infections in medical-surgical patients and in association with methylphenidate abuse. Medicine 1974; 53: 325–342
- Bruck C. Battle lines in the Ritalin war. Hum. Behav. 1976; August: 25–33
- Campbell S. B., Douglass V. I., Morgenstern G. Cognitive styles in hyperactive children and the effect of methylphenidate. J. Child Psychol. Psychiatry 1971; 12: 55–67
- Chambers C. D., Taylor W. J.R., Moffett A. D. The incidence of cocaine abuse among methadone maintenance patients. Int. J. Addict. 1972; 7: 427–441
- Cole S. O., Moore S. F. Stimulants and hyperkinesis: Drug use or abuse?. J. Drug Educ. 1975; 4: 371–378
- Conners C. K. Psychological effects of stimulant drugs in children with minimal brain dysfunction. Pediatrics 1972; 49: 702–708
- Grinspoon L., Singer S. Amphetamines in the treatment of hyperkinetic children. Harvard Educ. Rev. 1973; 43: 515–555
- Hahn H. H., Schweid A. I., Beaty H. N. Complications of injecting dissolved methylphenidate tablets. Arch. Intern. Med. 1969; 123: 656
- Jain N. C., Budd R. D., Sneath T. C. Frequency of use or abuse of amphetamine-related drugs. Am. J. Drug Alcohol Abuse 1979; 6: 33–57
- Janowski D. S., El-Yousef M. K., Davis J. M., Sekerke H. J. Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Arch. Gen. Psychiatry 1973; 28: 185–191
- Kalant O. J. The amphetamines, toxicity and addiction. University of Toronto Press, Toronto 1973
- Kaplitz S. E. Withdrawn, apathetic geriatric patients responsive to methylphenidate. J. Am. Geriatr. Soc. 1975; 23: 271–276
- Kramer J. C., Pinco R. Amphetamine use and misuse with recommendations for stimulant control policy. J. Psychedelic Drugs 1972; 5: 1139–1145
- Lewman L. V. Fatal pulmonary hypertension from intravenous injection of methylphenidate (Ritalin) tablets. Hum. Pathol. 1972; 3: 67–70
- Lucas A. R., Weiss M. Methylphenidate hallucinosis. J. Am. Med. Assoc. 1971; 217: 1079–1081
- Newmeyer J. A. The epidemiology of the use of amphetamine and related substances. J. Psychedelic Drugs 1978; 10: 293–302
- Raskind M., Bradford T. Methylphenidate (Ritalin) abuse and methadone maintenance. Dis. Nerv. Syst. 1975; January: 9–12
- Robbins M., Cowan R. B. Phased inpatient treatment of polydrug abusers. J. Psychedelic Drugs 1980; 12: 33–40
- Smith T. A., Kronick R. F. The policy culture of drugs: Ritalin, methadone, and the control of deviant behavior. Int. J. Addict. 1979; 14: 933–946
- Spensley J., Rockwell D. A. Psychosis during methylphenidate abuse. New Engl. J. Med. 1972; 286: 880–881
- Wesson D. R., Smith D. E. A clinical approach to diagnosis and treatment of amphetamine abuse. J. Psychedelic Drugs 1978; 10: 343–350